Meglutol: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)
ShiSheng (talk | contribs)
No edit summary
Line 25: Line 25:
| routes_of_administration =  
| routes_of_administration =  
}}
}}
{{CMG}}
{{CMG}} {{AE}}{{SS}}




Line 35: Line 35:
{{Lipid modifying agents}}
{{Lipid modifying agents}}


[[Category:Hypolipidemic agents]]
[[Category:Dicarboxylic acids]]
[[Category:Dicarboxylic acids]]
[[Category:Hypolipidemic agents]]
[[Category:Hypolipidemic agents]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 15:49, 24 July 2014

Meglutol
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC6H10O5
Molar mass162.141 g/mol
3D model (JSmol)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]


Overview

Meglutol (INN, also known as 3-hydroxy-3-methylglutaric acid, β-hydroxy-β-methylglutaric acid, and dicrotalic acid) is a hypolipidemic agent.


Template:Lipid modifying agents


Template:WikiDoc Sources